The European Respiratory Journal is voluntarily reviewed. We are most grateful for the hard work and dedication of all those who reviewed articles for the ERJ in 2022.
In conclusion, these observations show, for the first time to our knowledge, that being born SGA at term tracks into a shorter height in early adulthood but does not result in reduced lung function for that reduced height.
The Global Burden of Disease Study 2017 identified that a country’s sociodemographic index was a key factor affecting mortality and loss of health from respiratory diseases.
«Chronic airway diseases such as asthma and chronic obstructive pulmonary disease are prevalent and complex conditions that often coexist in the same patient. To address this complexity in clinical practice, and to move forward toward personalized and precision…»
Early diagnosis and treatment of COPD seems to be of paramount importance, and efforts are being devoted to the diagnosis of pre-COPD and COPD in young individuals…
La enfermedad pulmonar obstructiva crónica (EPOC) ha sido tradicionalmente entendida como una enfermedad autoinfligida por el hábito tabáquico que ocurre en adultos de más de 50-60 años. Este paradigma tradicional ha cambiado en los últimos 10 años por la aparición de nueva evidencia científica que muestra que existen otros muchos factores genéticos. (…)
COPD and lung cancer are highly prevalent causes of morbidity and mortality, worldwide. Their combined presence poses important challenges to diagnosis, treatment, and prognosis.
GOLD critically evaluates the new evidence since the previous publication and decides whether it merits (or not) inclusion in the most recent update.
Un grupo de neumólogos expertos en EPOC discuten 7 problemas fundamentales (“pecados capitales”) que contribuyen a incidencia creciente del EPOC, el gran impacto social y económico, con el objetivo explícito de proponer soluciones específicas que puedan contribuir a mejorar esta situación tan desfavorable.
The presence of CBI by any PPM, and one or more PA isolation, were independently associated with FEV1 decline in patients with COPD.
